Skip to content

EMPOWER PD - Feasibility of an Interdisciplinary Clinic for People With Parkinson's Disease

EMPOWER PD - Feasibility of an Interdisciplinary Clinic for People With Parkinson's Disease

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05640167
Enrollment
19
Registered
2022-12-07
Start date
2023-03-31
Completion date
2023-06-30
Last updated
2025-08-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parkinson Disease

Keywords

Patient-centric care, Interdisciplinary care, Parkinson Disease education

Brief summary

This study is a nonrandomized, pilot study of an interdisciplinary, patient-centric model of health care delivery in a boot camp style structured clinic for people diagnosed with Parkinson's disease (PwPD). 20 participants will attend a three session EMPOWER PD clinic and a two month follow up interview. The primary objective is to assess feasibility and acceptability of the newly developed clinic intervention as well as individual perception of experience and barriers.

Detailed description

This study is a nonrandomized, pilot study of an interdisciplinary, patient-centric model of health care delivery in a boot camp style structured clinic for people diagnosed with Parkinson's disease (PwPD). 20 participants will attend a three session EMPOWER PD clinic and a two month follow up interview. Participants will receive a comprehensive assessment by each member of an interdisciplinary team including physical therapy, speech therapy, nutrition, social work or psychology, and pharmacy. Participants will return the following week for a half day educational symposium. This is a group format and they will receive a session from each of the disciplines covering topics such as exercise, nutrition, communication, socialization, sleep hygiene, medication management, and coping. The final clinic session will be a one hour 1:1 meeting where individualized recommendations will be provided. A participant identified caregiver is invited/allowed to accompany the participant throughout the assessment and educational process whenever possible however, no information or questionnaires are being collected from them. The primary objective is to assess feasibility and acceptability of the newly developed clinic intervention as well as individual perception of experience and barriers with data derived from a program survey and semi-structured interview completed two months after clinic completion. Secondary objectives will test patient response to clinic intervention related to self-reported outcome measures (SROs) including Patient Centered Outcome Questionnaire PD, PD Knowledge, quality of life, fatigue, confidence with balance, and self-efficacy for exercise.

Interventions

BEHAVIORALInterdisciplinary Clinic

Interdisciplinary Clinic - assessment and recommendations by Nutrition, Pharmacy, Physical Therapy, and Speech Therapy and Educational Seminar - Parkinson's specific education and resources in group format

Sponsors

Brown University
CollaboratorOTHER
University of Rhode Island
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
40 Years to 100 Years
Healthy volunteers
No

Inclusion criteria

* A diagnosis of idiopathic Parkinson Disease * Living in the community (not institutionalized)

Exclusion criteria

* A diagnosis of atypical Parkinsonism * Institutionalized (living in a nursing home setting)

Design outcomes

Primary

MeasureTime frameDescription
Change in Health Education Impact QuestionnaireBaseline and End of Study - 2 MonthsSubjects score 42 items across 8 domains using a Likert-style question format indicated their strength of agreement by checking an option from 1 (strongly disagree) through 5 (strongly agree).
Feasibility and AccessibilityBaseline and End of Study - 2 MonthsFeasibility is measured by attendance and retention and survey completion rates. Attendance reported for each component of the clinic (clinic, seminar, 1:1 meeting, and follow-up interview). Retention reflects the number of participants that participated in all 4 components. Survey completion rates reflect the number of participants that completed all self report measures at Baseline and End of Study.
Feasibility: Program SurveyEnd of Study - 2 MonthsA series of 12 statements regarding acceptability, process, barriers, and perception of experience of clinic will be scored by participants on a scale of 1 (disagree) to 5 (agree) with a higher score on each statement indicating more positive outcome. The average response per question is reported below.
Change in Patient Centered Outcome QuestionnaireBaselineParkinson's Disease (PCOQ-PD) The PCOQ-PD evaluates treatment success and expectations from the patient's perspective across 10 motor and non-motor functional domains grouped into four sections. Patients are asked to rate for each domain with each section: (1) their usual levels of self-defined difficulty over the past week, (2) their success criteria for treatment outcomes, (3) their expectations for their treatment, regardless of their previous treatment experiences, and (4) how important it was for them to see improvement. Participants used a 101-point numerical rating scale to indicate their rating, anchored by 0 (None) to 100 (Worst Imaginable) for the first three sections and by 0 (Not at All Important) to 100 (Most Important) for the fourth section. The mean response and standard deviation are reported below.
Parkinson's Disease Knowledge QuestionnaireBaseline and End of Study - 2 monthsKnowledge regarding Parkinson's disease as measured by the Parkinson's Disease Knowledge Questionnaire (PDKQ). Participants indicate their knowledge of 26 items related to Parkinson's disease with a true or false response.

Secondary

MeasureTime frameDescription
Change in Balance Confidence Measured With the Activities-specific Balance Confidence (ABC) Scale.Baseline and End of Study - 2 MonthsThe ABC is The ABC is an 16 question survey and ratings should consist of whole numbers (0-100) for each item. Total the ratings (possible range = 0 - 1600) and divide by 16 to get each subject's ABC score which is a percentage of agreement out of 100%.
Change in Quality of Life Measured With the Parkinson Disease Questionnaire-39 (PDQ-39)Baseline and End of Study - 2 MonthsThe PDQ-39 is a 39-item self-report questionnaire, which assesses Parkinson's disease-specific health related quality over the last month covering 8 dimensions scored on a 5 point ordinal system (0=never, 4=always). Dimension score = sum of scores of each item in the dimension divided by the maximum possible score of all the items in the dimension, multiplied by 100. Each dimension total score range from 0 (never have difficulty) to 100 (always have difficulty). Lower scores reflect better QoL. Overall score can be summarized in the Parkinson's Disease Summary Index (PDSI) or PDQ-39 Summary Index (PDQ-39 SI).PDSI or PDQ-39 SI = sum of dimension total scores divided by 8 which then reflects a mean score ranging from 0 to 19.5 with a lower number reflecting better quality of life.
Change in the Parkinson's Fatigue Scale (PFS-16).Baseline and End of Study - 2 MonthsThe PFS-16 is a 16-item patient rated scale based on feelings and experiences over the past two weeks. Seven items tap the presence or absence of the subjective experience of fatigue with an emphasis on the physical effects of fatigue and nine items address the impact of fatigue on daily functioning and activities, including socialization and work but not exercise specifically. Scoring options range from 1 (strongly disagree) to 5 (strongly agree). A total ordinal PFS score ranging from 16-80 based on the sum of the scores will be used.
Change in Self-Efficacy for ExerciseBaseline and End of Study - 2 MonthsSelf-Efficacy for Exercise scale consists of nine situations (weather, boredom, exercising alone, not pleasurable, too busy, feel tired, stress, depressed) that might effect participation in exercise For each situation, the subject uses the scale from 0 (not confident) to 10 (very confident) to describe their current confidence that they could exercise 3 times a week for 20 minutes each time. Total score is calculated by summing the responses to each question. This scale has a range of total scores from 0-90. A higher score indicates higher self-efficacy for exercise. Participants total score was then divided by 90 to convert to a percentage.

Countries

United States

Participant flow

Recruitment details

Twenty-three individuals were screened for the clinic. Two were unable to attend due to limited weekend availability of the clinic, a third could not attend due to geographic/driving barriers, and the remaining 20 were confirmed to attend the EMPOWER PD Clinic in one of two locations offered. One individual was a no show to the clinic resulting in 19 participants enrolled in the study.

Participants by arm

ArmCount
EMPOWER PD Clinic Participation
All participants were assigned to the same interdisciplinary clinic and educational intervention Interdisciplinary Clinic: Interdisciplinary Clinic - assessment and recommendations by Nutrition, Pharmacy, Physical Therapy, and Speech Therapy and Educational Seminar - Parkinson's specific education and resources in group format
19
Total19

Baseline characteristics

CharacteristicEMPOWER PD Clinic Participation
Age, Categorical
<=18 years
0 Participants
Age, Categorical
>=65 years
11 Participants
Age, Categorical
Between 18 and 65 years
8 Participants
Age, Continuous68.53 years
STANDARD_DEVIATION 8.11
Education level
College degree
12 Participants
Education level
Some College or Vocational School
5 Participants
Education level
Up to High School or GED
2 Participants
Ethnicity (NIH/OMB)
Hispanic or Latino
1 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
18 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants
Montreal Cognitive Assessment26.26 units on a scale
STANDARD_DEVIATION 4.98
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
Race (NIH/OMB)
Asian
0 Participants
Race (NIH/OMB)
Black or African American
0 Participants
Race (NIH/OMB)
More than one race
0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants
Race (NIH/OMB)
White
19 Participants
Region of Enrollment
United States
19 participants
Sex: Female, Male
Female
5 Participants
Sex: Female, Male
Male
14 Participants
Stage of Parkinson's Disease
Adavanced Stage (>10 years)
4 Participants
Stage of Parkinson's Disease
Early Stage (0-4 years)
9 Participants
Stage of Parkinson's Disease
Mid Stage (5-10 years)
6 Participants
Years Living with Parkinson's Disease6.1 years
STANDARD_DEVIATION 5.45

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 19
other
Total, other adverse events
0 / 19
serious
Total, serious adverse events
0 / 19

Outcome results

Primary

Change in Health Education Impact Questionnaire

Subjects score 42 items across 8 domains using a Likert-style question format indicated their strength of agreement by checking an option from 1 (strongly disagree) through 5 (strongly agree).

Time frame: Baseline and End of Study - 2 Months

Population: One participant was dropped from the analysis due to cognitive impairment and difficulty completing the questionnaire

ArmMeasureGroupValue (MEAN)Dispersion
EMPOWER PD Clinic ParticipationChange in Health Education Impact QuestionnaireEmotional well-being - Pre Assess2.93 score on a scale 1 to 5Standard Deviation 0.25
EMPOWER PD Clinic ParticipationChange in Health Education Impact QuestionnairePostive engagement - Pre Assess3.78 score on a scale 1 to 5Standard Deviation 0.85
EMPOWER PD Clinic ParticipationChange in Health Education Impact QuestionnairePostive engagement - Post Assess4.18 score on a scale 1 to 5Standard Deviation 0.73
EMPOWER PD Clinic ParticipationChange in Health Education Impact QuestionnaireHealth directed activities - Pre Assess3.28 score on a scale 1 to 5Standard Deviation 0.4
EMPOWER PD Clinic ParticipationChange in Health Education Impact QuestionnaireHealth directed activities - Post Assess3.58 score on a scale 1 to 5Standard Deviation 0.42
EMPOWER PD Clinic ParticipationChange in Health Education Impact QuestionnaireSkill and Technique Aquisition - Pre Assess3.02 score on a scale 1 to 5Standard Deviation 0.21
EMPOWER PD Clinic ParticipationChange in Health Education Impact QuestionnaireSkill and Technique Aquisition - Post Assess3.32 score on a scale 1 to 5Standard Deviation 0.39
EMPOWER PD Clinic ParticipationChange in Health Education Impact QuestionnaireConstructive Attitudes - Pre Assess3.22 score on a scale 1 to 5Standard Deviation 0.38
EMPOWER PD Clinic ParticipationChange in Health Education Impact QuestionnaireConstructive Attitudes - Post Assess3.67 score on a scale 1 to 5Standard Deviation 0.34
EMPOWER PD Clinic ParticipationChange in Health Education Impact QuestionnaireSelf monitoring and insight - Pre Assess3.13 score on a scale 1 to 5Standard Deviation 0.2
EMPOWER PD Clinic ParticipationChange in Health Education Impact QuestionnaireSelf monitoring and insight - Post Assess3.48 score on a scale 1 to 5Standard Deviation 0.35
EMPOWER PD Clinic ParticipationChange in Health Education Impact QuestionnaireHealth service navigation - Pre Assess3.22 score on a scale 1 to 5Standard Deviation 0.34
EMPOWER PD Clinic ParticipationChange in Health Education Impact QuestionnaireHealth service navigation - Post Assess3.47 score on a scale 1 to 5Standard Deviation 0.55
EMPOWER PD Clinic ParticipationChange in Health Education Impact QuestionnaireSocial integration and support - Pre Assess3.14 score on a scale 1 to 5Standard Deviation 0.35
EMPOWER PD Clinic ParticipationChange in Health Education Impact QuestionnaireSocial integration and support - Post Assess3.37 score on a scale 1 to 5Standard Deviation 0.55
EMPOWER PD Clinic ParticipationChange in Health Education Impact QuestionnaireEmotional well-being - Post Assess2.70 score on a scale 1 to 5Standard Deviation 0.52
p-value: 0.114t-test, 2 sided
Primary

Change in Patient Centered Outcome Questionnaire

Parkinson's Disease (PCOQ-PD) The PCOQ-PD evaluates treatment success and expectations from the patient's perspective across 10 motor and non-motor functional domains grouped into four sections. Patients are asked to rate for each domain with each section: (1) their usual levels of self-defined difficulty over the past week, (2) their success criteria for treatment outcomes, (3) their expectations for their treatment, regardless of their previous treatment experiences, and (4) how important it was for them to see improvement. Participants used a 101-point numerical rating scale to indicate their rating, anchored by 0 (None) to 100 (Worst Imaginable) for the first three sections and by 0 (Not at All Important) to 100 (Most Important) for the fourth section. The mean response and standard deviation are reported below.

Time frame: Baseline

ArmMeasureGroupValue (MEAN)Dispersion
EMPOWER PD Clinic ParticipationChange in Patient Centered Outcome QuestionnairePain - Importance34.47 score on a scaleStandard Deviation 9.22
EMPOWER PD Clinic ParticipationChange in Patient Centered Outcome QuestionnaireFatigue - Importance50.26 score on a scaleStandard Deviation 8.25
EMPOWER PD Clinic ParticipationChange in Patient Centered Outcome QuestionnaireEmotional Distress - Importance Emotional Distress - Importance33.16 score on a scaleStandard Deviation 8.21
EMPOWER PD Clinic ParticipationChange in Patient Centered Outcome QuestionnaireInterference with ADLs - Importance41.48 score on a scaleStandard Deviation 8.17
EMPOWER PD Clinic ParticipationChange in Patient Centered Outcome QuestionnaireTremor - Importance36.58 score on a scaleStandard Deviation 7.99
EMPOWER PD Clinic ParticipationChange in Patient Centered Outcome QuestionnaireStiffness - Importance56.05 score on a scaleStandard Deviation 8.72
EMPOWER PD Clinic ParticipationChange in Patient Centered Outcome QuestionnaireSlowness - Importance45.53 score on a scaleStandard Deviation 8.39
EMPOWER PD Clinic ParticipationChange in Patient Centered Outcome QuestionnaireWalking Problems - Importance51.32 score on a scaleStandard Deviation 9.23
EMPOWER PD Clinic ParticipationChange in Patient Centered Outcome QuestionnaireThnking Porblems - Importance51.84 score on a scaleStandard Deviation 9.15
EMPOWER PD Clinic ParticipationChange in Patient Centered Outcome QuestionnaireSleep Problems - Importance38.95 score on a scaleStandard Deviation 8.57
Primary

Feasibility and Accessibility

Feasibility is measured by attendance and retention and survey completion rates. Attendance reported for each component of the clinic (clinic, seminar, 1:1 meeting, and follow-up interview). Retention reflects the number of participants that participated in all 4 components. Survey completion rates reflect the number of participants that completed all self report measures at Baseline and End of Study.

Time frame: Baseline and End of Study - 2 Months

ArmMeasureGroupValue (COUNT_OF_PARTICIPANTS)
EMPOWER PD Clinic ParticipationFeasibility and AccessibilityAttendance Clinic19 Participants
EMPOWER PD Clinic ParticipationFeasibility and AccessibilityAttendance Seminar19 Participants
EMPOWER PD Clinic ParticipationFeasibility and AccessibilityAttendance 1:119 Participants
EMPOWER PD Clinic ParticipationFeasibility and AccessibilityAttendance Interview19 Participants
EMPOWER PD Clinic ParticipationFeasibility and AccessibilityRetention Rate19 Participants
EMPOWER PD Clinic ParticipationFeasibility and AccessibilitySurvey Completion Baseline18 Participants
EMPOWER PD Clinic ParticipationFeasibility and AccessibilitySurvey Completion End of study18 Participants
Primary

Feasibility: Program Survey

A series of 12 statements regarding acceptability, process, barriers, and perception of experience of clinic will be scored by participants on a scale of 1 (disagree) to 5 (agree) with a higher score on each statement indicating more positive outcome. The average response per question is reported below.

Time frame: End of Study - 2 Months

ArmMeasureGroupValue (MEAN)Dispersion
EMPOWER PD Clinic ParticipationFeasibility: Program SurveyQuestion 1 - The clinic was located in an area of RI that was accessible to me.4.947 units on a scaleStandard Deviation 0.229
EMPOWER PD Clinic ParticipationFeasibility: Program SurveyQuestion 2 - Parking was easy and accessible4.947 units on a scaleStandard Deviation 0.229
EMPOWER PD Clinic ParticipationFeasibility: Program SurveyQuestion 3 - The building where I attended the clinic was accessible.4.947 units on a scaleStandard Deviation 0.229
EMPOWER PD Clinic ParticipationFeasibility: Program SurveyQuestion 4 - The clinic was well organized.4.947 units on a scaleStandard Deviation 0.229
EMPOWER PD Clinic ParticipationFeasibility: Program SurveyQuestion 5 - It was helpful to be seen by the physical therapist.4.947 units on a scaleStandard Deviation 0.229
EMPOWER PD Clinic ParticipationFeasibility: Program SurveyQuestion 6 - It was helpful to be seen by the speech language pathologist.4.894 units on a scaleStandard Deviation 0.315
EMPOWER PD Clinic ParticipationFeasibility: Program SurveyQuestion 7 - It was helpful to be seen by the nutritionist.4.842 units on a scaleStandard Deviation 0.501
EMPOWER PD Clinic ParticipationFeasibility: Program SurveyQuestion 8 - It was helpful to be seen by the pharmacist.4.789 units on a scaleStandard Deviation 0.535
EMPOWER PD Clinic ParticipationFeasibility: Program SurveyQuestion 9 - The four-hour educational seminar increased my knowledge4.789 units on a scaleStandard Deviation 0.418
EMPOWER PD Clinic ParticipationFeasibility: Program SurveyQuestion 10 - I feel more confident with my ability to access resources in RI4.578 units on a scaleStandard Deviation 0.6
EMPOWER PD Clinic ParticipationFeasibility: Program SurveyQuestion 11 - I have made progress on the individual goals I identified during the clinic4.368 units on a scaleStandard Deviation 0.683
EMPOWER PD Clinic ParticipationFeasibility: Program SurveyQuestion 12 - Participating in EMPOWER PD added value to my ability to manage my Parkinson's disease4.842 units on a scaleStandard Deviation 0.374
Primary

Parkinson's Disease Knowledge Questionnaire

Knowledge regarding Parkinson's disease as measured by the Parkinson's Disease Knowledge Questionnaire (PDKQ). Participants indicate their knowledge of 26 items related to Parkinson's disease with a true or false response.

Time frame: Baseline and End of Study - 2 months

Population: One participant was dropped from the analysis due to cognitive impairment and difficulty completing the questionnaire

ArmMeasureGroupValue (MEAN)Dispersion
EMPOWER PD Clinic ParticipationParkinson's Disease Knowledge QuestionnairePDKQ Pre-Assess66.03 percentage of correct answersStandard Deviation 10.23
EMPOWER PD Clinic ParticipationParkinson's Disease Knowledge QuestionnairePDKQ Post-Assess75.21 percentage of correct answersStandard Deviation 12.32
p-value: 0.015t-test, 2 sided
Secondary

Change in Balance Confidence Measured With the Activities-specific Balance Confidence (ABC) Scale.

The ABC is The ABC is an 16 question survey and ratings should consist of whole numbers (0-100) for each item. Total the ratings (possible range = 0 - 1600) and divide by 16 to get each subject's ABC score which is a percentage of agreement out of 100%.

Time frame: Baseline and End of Study - 2 Months

Population: One participant was dropped from the analysis due to cognitive impairment and difficulty completing the questionnaire

ArmMeasureGroupValue (MEAN)Dispersion
EMPOWER PD Clinic ParticipationChange in Balance Confidence Measured With the Activities-specific Balance Confidence (ABC) Scale.ABC Pre Assess80.79 percentage of agreement with statementsStandard Deviation 15.41
EMPOWER PD Clinic ParticipationChange in Balance Confidence Measured With the Activities-specific Balance Confidence (ABC) Scale.ABC Post Assess85.37 percentage of agreement with statementsStandard Deviation 12.74
p-value: 0.03t-test, 2 sided
Secondary

Change in Quality of Life Measured With the Parkinson Disease Questionnaire-39 (PDQ-39)

The PDQ-39 is a 39-item self-report questionnaire, which assesses Parkinson's disease-specific health related quality over the last month covering 8 dimensions scored on a 5 point ordinal system (0=never, 4=always). Dimension score = sum of scores of each item in the dimension divided by the maximum possible score of all the items in the dimension, multiplied by 100. Each dimension total score range from 0 (never have difficulty) to 100 (always have difficulty). Lower scores reflect better QoL. Overall score can be summarized in the Parkinson's Disease Summary Index (PDSI) or PDQ-39 Summary Index (PDQ-39 SI).PDSI or PDQ-39 SI = sum of dimension total scores divided by 8 which then reflects a mean score ranging from 0 to 19.5 with a lower number reflecting better quality of life.

Time frame: Baseline and End of Study - 2 Months

Population: One participant was dropped from the analysis due to cognitive impairment and difficulty completing the questionnaire

ArmMeasureGroupValue (MEAN)Dispersion
EMPOWER PD Clinic ParticipationChange in Quality of Life Measured With the Parkinson Disease Questionnaire-39 (PDQ-39)PDQ-39 SI Pre Assess3.93 score on a scaleStandard Deviation 2.27
EMPOWER PD Clinic ParticipationChange in Quality of Life Measured With the Parkinson Disease Questionnaire-39 (PDQ-39)PDQ-39 SI Post Assess4.22 score on a scaleStandard Deviation 2.6
p-value: 0.309t-test, 2 sided
Secondary

Change in Self-Efficacy for Exercise

Self-Efficacy for Exercise scale consists of nine situations (weather, boredom, exercising alone, not pleasurable, too busy, feel tired, stress, depressed) that might effect participation in exercise For each situation, the subject uses the scale from 0 (not confident) to 10 (very confident) to describe their current confidence that they could exercise 3 times a week for 20 minutes each time. Total score is calculated by summing the responses to each question. This scale has a range of total scores from 0-90. A higher score indicates higher self-efficacy for exercise. Participants total score was then divided by 90 to convert to a percentage.

Time frame: Baseline and End of Study - 2 Months

Population: One participant was dropped from the analysis due to cognitive impairment and difficulty completing the questionnaire

ArmMeasureGroupValue (MEAN)Dispersion
EMPOWER PD Clinic ParticipationChange in Self-Efficacy for ExerciseSelf-Efficacy for Exercise - Pre Assess64.82 percentage of agreement with statementsStandard Deviation 20.77
EMPOWER PD Clinic ParticipationChange in Self-Efficacy for ExerciseSelf-Efficacy for Exercise - Post Assess67.10 percentage of agreement with statementsStandard Deviation 20.88
p-value: 0.59t-test, 2 sided
Secondary

Change in the Parkinson's Fatigue Scale (PFS-16).

The PFS-16 is a 16-item patient rated scale based on feelings and experiences over the past two weeks. Seven items tap the presence or absence of the subjective experience of fatigue with an emphasis on the physical effects of fatigue and nine items address the impact of fatigue on daily functioning and activities, including socialization and work but not exercise specifically. Scoring options range from 1 (strongly disagree) to 5 (strongly agree). A total ordinal PFS score ranging from 16-80 based on the sum of the scores will be used.

Time frame: Baseline and End of Study - 2 Months

Population: One participant was dropped from the analysis due to cognitive impairment and difficulty completing the questionnaire

ArmMeasureGroupValue (MEAN)Dispersion
EMPOWER PD Clinic ParticipationChange in the Parkinson's Fatigue Scale (PFS-16).PFS-16 Pre Assess40.39 score on a scaleStandard Deviation 14.01
EMPOWER PD Clinic ParticipationChange in the Parkinson's Fatigue Scale (PFS-16).PFS-16 Post Assess40.67 score on a scaleStandard Deviation 14.39
p-value: 0.827t-test, 2 sided

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026